Skip to content

Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy

Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy - Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000040019
Enrollment
20
Registered
2020-04-14
Start date
2020-04-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary malignancy

Interventions

Robotic-assisted surgery is performed using the da Vinci Surgical System x, and the target procedure is &quot
thoracoscopic pulmonary malignancy surgery (resection of the lung lobes or more than one lung lobe with endoscopic surgical support equipment). It is. The treatment and diagnostic policies and the ext

Sponsors

he Division of Thoracic Surgery, the Department of Surgery, the Jikei University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PS (Performance Status) is 0 or 1. No prior treatment for the disease. Consent to participate in the study has been obtained in writing. Diagnosis of pulmonary malignancy has been obtained by preoperative imaging or pathological examination. In the case of primary lung malignancy, preoperative imaging indicates that the clinical stage of lung cancer is stage I-II. In the case of metastatic pulmonary malignancy, no metastasis is observed in organs other than the lung.

Exclusion criteria

Exclusion criteria: PS (Performance Status) is 0 or 1. No prior treatment for the disease. Consent to participate in the study has been obtained in writing. Diagnosis of pulmonary malignancy has been obtained by preoperative imaging or pathological examination. In the case of primary lung malignancy, preoperative imaging indicates that the clinical stage of lung cancer is stage I-II. In the case of metastatic pulmonary malignancy, no metastasis is observed in organs other than the lung.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative complications

Secondary

MeasureTime frame
Robotic surgery completion rate, intraoperative blood loss, operative time, length of hospital stay, medical costs, recurrence-free survival and overall survival

Countries

Japan

Contacts

Public ContactHIDEKI MATSUDAIRA

The Jikei University School of Medicine The Division of Thoracic Surgery, the Department of Surgery

hideki.matsudaira@gmail.com0334331111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026